伟思医疗：第三季度归母净利润3282.4万元，同比增长14.99%

Core Viewpoint - Weisi Medical reported a revenue of 115 million yuan for Q3 2025, marking a year-on-year increase of 14.87% and a net profit attributable to shareholders of 32.824 million yuan, up 14.99% [1] Financial Performance - For the first three quarters, the company achieved a revenue of 326 million yuan, reflecting a year-on-year growth of 11.58% [1] - The net profit attributable to shareholders for the same period reached 102 million yuan, showing a significant year-on-year increase of 30.68% [1] - Basic earnings per share for Q3 2025 were reported at 0.35 yuan [1]